Day 1: Wednesday, September 13, 2017

Global Biobank Week Opening Ceremony

  Jan-Eric Litton
  Elke Smits
  Brent Schacter

Session 1: Keynote Plenary

 LEAD KEYNOTE: Gregory C. Simon

Gregory C. Simon is the President of the Biden Cancer Initiative. In this role he if working to develop and drive implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce disparities in cancer outcomes.

Previously, he was the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama for which he was chosen by Vice President Joe Biden in March 2016. As Executive Director, Greg assembled and led a team of eight professionals to support the work of the Vice President in developing and promoting the goals of the Cancer Moonshot in numerous meetings and presentations and to coordinate the work of the Task Force comprised of twenty cabinet and sub-cabinet offices.

Greg Simon has held senior positions in both chambers of Congress and the White House, been a senior strategy consultant to a variety of international technology CEO’s, led a national patient advocacy nonprofit he co-founded with Mike Milken and served as a senior executive at a large pharmaceutical corporation. He has developed a reputation as a visionary strategist, a dynamic public speaker and writer, and as a knowledgeable analyst of emerging trends in healthcare, information technology, innovative drug research and development and patient advocacy.

Session 2A: Keynote Plenary 2

  KEYNOTE: Jan-Eric Litton
Jan-Eric Litton received his PhD from Karolinska Institutet in 1983. In 2002, he was appointed professor of biomedical computing technology at Karolinska Institutet. He was one of the driving forces behind the initiative that later evolved into BBMRI-ERIC and was BBMRI-ERIC’s first Director General from January 2014 to July 2017. Professor Litton was Executive Director and head of the largest medical infrastructure in Sweden,, and was coordinator of the Nordic BBMRI, a northern European research infrastructure. The first edition of the HandsOn: Biobank Congress, the predecessor of the Europe Biobank Week, saw the light in Uppsala in 2012. In 2015, he led the initiative in creating the Global Biobank Week.

Session 2B: Insights and Experiences of Healthcare Integrated Biobanking for Rapid Progess in the Development of New Diagnostic Markers and Tools for Personalised Medicine - A Swedish Perspective

  Tobias Sjöblom
  Tobias Sjöblom is a professor in cancer genetics at Uppsala University, Sweden. His research interests center on the acquired mutations that cause colorectal cancer and their applications in diagnostics and therapeutics. He is Program Director for U-CAN, a longitudinal cancer biobank serving academic and corporate research encompassing >12.000 patients ( He has a leading role in the coming national biobank infrastructure Biobank Sweden.
  Margaretha Persson

Margaretha Persson is associate professor in Cardiovascular Epidemiology at the University of Lund since 2016 and is co-principal investigator of SCAPIS. She is also head of the clinical research unit at Malmö University Hospital since 2002.

She is a registered nurse with a master degree in public health, and gained her PhD in Cardiovascular Epidemiology in 2008.

  Henrik Grönberg

Professor Henrik Grönberg has been the chairman of the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet since 2008. This department is one of the largest departments of epidemiology and biostatistics in Europe, with over 270 employees.

Professor Grönberg earned his medical and doctoral degree at Umeå University in 1985 and 1995, respectively. In 2001, he was appointed professor of oncology at Umeå University and in 2005 professor of cancer epidemiology at Karolinska Institutet. He is also a board certified medical oncologist since 1994 and has been working at the Oncology Clinic at Umeå University Hospital between 1989 and 2005. At Umeå University Hospital he was also responsible for the cancer genetic clinic, including genetic counselling and mutation screening.

His main research area is prostate cancer genetics and he has authored approximately 200 peer-reviewed articles in international scientific journals. He has been part of localising the first two prostate cancer susceptibility loci in 1996 and 1998, and identifying several new prostate cancer susceptibility loci in 2006 to 2012. He is currently the PI the large randomized clinical trial (STHLM3) in Stockholm including over 260 000 men, aimed at evaluating new prostate cancer diagnostic tests. He also has an ongoing research program using prostate cancer tumours, trying to develop tissue-based prognostic tests using next generation sequencing.

Professor Grönberg has served as chair of the study section of cancer epidemiology at the Swedish Cancer Society between 2002 and 2009. He has been the Swedish representative at the WHO agency IARC (International Agency of Cancer Research) in Lyon between 2008 and 2011.

Session 3A: The Measure of Success - Metrics Used to Describe the Utilisation of Biobanked Samples

  Carmen Swanepoel
  Carmen is a molecular biologist within the division of haematopathology and jointly appointed by the National Health Laboratory Services (NHLS) and Stellenbosch University (SU) at Tygerberg Hospital, Western Cape, South Africa. She has been concerned with research and teaching/training of staff and students in laboratory skills and is currently overseeing the cell culture facility and the NHLS/Stellenbosch University Biobank (NSB) within the faculty’s pathology department. The bulk of her time is spent in the role of scientific and operational manager of NSB along with Professor Abayomi (PI) and the Governance Advisory Board (GAP). Carmen oversee's the day to day biobanking operations in association with other research and technical staff. She is GCP, GLP and IATA certified and also the Laboratory’s first aid trainer. Over the years she has gained expertise in other biobank and genomic related operations ranging from governance, ethics, LIMS, sample and data protection, sample QC, risk management and QA through to sustainability.
  Mehdi Kara-Borni
  Master’s student in “Biobanks and Complex Data Management” at the Université Côte d’Azur (Nice, France). Intern at the LPCE Hospital Biobank (Nice, France).
He holds a degree in life and health science. Currently during his Master training, he’s acquiring several skills related to the biobanking field such as: quality control, ethics, “biobankonomics”, data management, project management, technical expertise.
  Kazuyuki Matsushita

Professional Experience:

  • 2008-present Clinical Professor, Department Laboratory Medicine, Chiba University Hospital, Japan
  • 2015 Board of Laboratory Medicine, Japanese Society of Laboratory Medicine Japanese Board of Medical Genetics, The Japan Society of Human Genetics
  • 2010 Board of Specialty in Cancer Treatment, Society of Japanese Cancer Treatment Society
  • 2006-2008 Assistant Professor, Department of Emergency and Critical Care Medicine; Division of Artificial Organs and Hemodialysis, Chiba University, Japan
  • 2005 Board of Specialty in Gastrointestinal Surgery, Society of Japan Gastrointestinal Surgery
  • 2002 Board of Specialty in Surgery, Japan Surgical Society
  • 1997-2000 Visiting Fellow of the NCI, NIH, USA
  • 1995-1997 Senior Resident of Surgery, National Sakura Hospital
  • 1991-1995 PhD (Dr. of Medical Science), Chiba University
  • 1990-1991 Junior Resident of Surgery, Chiba Cancer Center Hospital Education & Board
  • 1982-1988 MD, Chiba University
  Pablo Isidro-Marrón
  Pablo Isidro Marrón is the coordinator of Principado de Asturias Biobank, in Spain, since 2010. He is a graduate in chemistry of the University of Oviedo and specialist of clinic biochemistry at the Hospital Universitari de Bellvitge in Barcelona. He is responsible for the Biobank quality management system, president of  the ISO committe in Asturias, and member of the quality committee of the Spanish National Network of Biobanks. He coordinates the quality management system working line and works by internal auditor in ISO 9001 at Asturias Health Public System.

Session 3B: Regulating Across the World - Re-Using and Sharing Resources, Data, and Samples

  Yali Cong
Yali Cong was trained in Biology in Beijing Normal University and Philosophy in People’s University, China. She has been involved in research and teaching at Peking University Health Science Center (PUHSC) since she received her PhD in 1995. She teaches medical ethics to clinical medical students and supervises graduate students. After the SARS outbreak in Beijing, she and her colleagues at the school of public health in PUHSC initiated a public health ethics program. Since 2010, she has been the Chair of IRB and is working with other leaders to establish the first Human Subject Protection Program at Peking University. In 2008, she set up a joint center for medical professionalism with IMAP and the University of Columbia. She serves as the vice chair of the China Medical Ethics Association, and is a member of a number of international organizations, including WHO and IAB. She has published 50 papers in English and Chinese.
  Keymanthri Moodley
Keymanthri Moodley is a Professor in the Department of Medicine and Director of the Centre for Medical Ethics and Law, Department of Medicine, Faculty of Health Sciences, Stellenbosch University. In 2017, she was appointed Adjunct Professor, Department of Social Medicine, University of North Carolina-Chapel Hill, USA. Keymanthri is a family physician who currently works as a bioethicist. In 2013 she was rated by the National Research Foundation (NRF) as an established researcher based on her numerous national and international publications, conference presentations, her role on national bodies like the MRC Board and the National Health Research Ethics Council (NHREC), and her involvement in international organisations such as the World Health Organisation (WHO), International AIDS Society (IAS), and NIH DSMBs. She has worked as principal investigator on clinical trials since 1999, and served on the University Research Ethics Committee (REC) for 10 years. The Centre that she has directed for the past 14 years was designated as a Collaborating Centre in Bioethics by the WHO, one of seven in the world and the first on the African continent. The main activities of the Centre include bioethics teaching, empirical research in bioethics and clinical ethics consultation. Since 2011, Keymanthri has co-hosted an NIH Fogarty program to develop capacity in Health Research Ethics in Africa in collaboration with the Bioethics Center, University of North Carolina-Chapel Hill, USA. This program has graduated 40 postgraduate scholars from 10 African countries over the past 4 years. In 2013 she was awarded a second NIH grant to examine the ethical and social issues associated with HIV Cure research. In 2015 the Centre was awarded its third NIH grant to explore ethical, legal, and social issues related to genomic biobanking. Keymanthri is a member of the Academy of Science in South Africa. She completed an Executive MBA in 2015. Since November 2016 she has chaired the REC of the South African Medical Research Council and qualified as an Associate Executive Coach in the same year. In 2017 she was awarded her 4th NIH grant to develop a Leadership Program in Bioethics. This will include a doctoral program in Clinical and Research Ethics – the first NIH funded program of its kind based in Africa. Keymanthri was recently appointed as a member of the Scientific Advisory Committee of the European and Developing Countries Clinical Trials Program (EDCTP). She has 2 sons, Kehar (25) and Nikhal (20). In her leisure time she enjoys gardening, dancing, and mindfulness practices.
  Irene Schlünder
  Irene Schlünder is a lawyer and the German expert in the BBMRI-ERIC Common Service ELSI. She graduated in law at the University of Heidelberg and worked several years as a researcher at the University of Potsdam, focusing and publishing on human rights. She has also long experience as attorney at law with a focus on privacy law and on IP law. Due to her expertise in EU data protection law, Irene Schlünder supports a variety of European research projects aiming to enhance translational and transnational medical research while maintaining a high data protection standard.
  Deborah Mascalzoni, PhD
  Deborah Mascalzoni is a senior scientist at Uppsala University Sweden and at EURAC research in Italy. She is working on ELSI of biobanking and registries both in the rare diseases (RD-connect, Euroteam, BT-Cure) and in the population’s studies area (CHRIS). Holding a PhD in Bioethics from the Faculty of Law at Bologna University, she has been teaching ethics and bioethics in Italy and Sweden. Her main research interests are genetics and new technologies including informed consent, patient communication, privacy, and data sharing. She extensively worked on projects regarding research/participants dynamic interaction and dynamic consent. Dr. Mascalzoni, has obtained over 600.000 Euro in grant applications from both European and Italian funding bodies. She has written over 28 articles, 5 book chapters and published one book. She has an extensive record of teaching bioethics and research ethics. She is an advisor for different projects and a member of different international and national ethical boards.
  Mark Rothstein
  Coming soon.
  Gauthier Chassang
  Coming soon.

Session 3C: Quality Management for Biobanking

  Joakim Lundeberg
Professor Joakim Lundeberg heads the division of gene technology, KTH based at the Science for Life Laboratory. The current research focus of Joakim relates to spatially resolved gene expression studies, spatial transcriptomics (Ståhl et al, Science, 2016), and single cell sequencing (Vickovic et al, Nature Comm, 2016). In the work recently published a method is described that allows studies of gene expression in tissue sections using RNA-sequencing to uncover transcriptional patterns in situ. Joakim also heads the National Genomics Infrastructure that has a staff of >70 full time employees which renders NGI as one of the largest sequencing centers in Europe.
  Jane Carpenter
  Jane Carpenter has been involved in biobanking in medical research for 15 years. She is the manager of biobanking for NSW Health Pathology who supply diagnostic pathology service for all public patients in the state of New South Wales, Australia. She has been involved in national and international biobanking organisations - Australasian Biobanking Network Association, member of Board of Asian Network of Research Resource Centres (ANRRC) and member of ISBER Board of Directors from 2011-2017. She is chair of the Standards Australia mirror committee for ISO 276. Jane's current position involves developing a statewide framework for biobanking and the establishment and commissioning of a centralised biobank facility
  Lovice Sutherland
  In 1985 Lovice completed her General Nursing Diploma at Lincoln Institute of Health Sciences, Melbourne and in 1987 attained her Bachelor of Applied Science with a midwifery major at La Trobe University, Melbourne. Some years later she married and moved to the Netherlands and made a career change. Lovice is currently working as a staff member on the Radboud Biobank management team and since the establishment in 2012 has been in a management support role which includes implementing and overseeing the quality management system.
  Liangliang Ruan
  Liangliang Ruan, PhD, is the director of the Biobank Department, Shanghai Clinical Research Center (SCRC), and deputy director of the Shanghai Engineering Research Center of Biobank (SERCB). Dr. Ruan graduated from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences in 2012. After initially working as a manager of the biobank at the Shanghai Clinical Research Center (SCRC) in 2013, he is currently the director of the Biobank Department of SCRC, responsible for general operations, personnel supervision and the quality management system. Dr. Ruan has developed a quality management system for biobanking at SCRC, managed the sampling project for biospecimen quality control in the China Biobank Network, has published more than 10 papers and has been granted 5 patents.